306 related articles for article (PubMed ID: 7690328)
1. Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.
Durandy A; Schiff C; Bonnefoy JY; Forveille M; Rousset F; Mazzei G; Milili M; Fischer A
Eur J Immunol; 1993 Sep; 23(9):2294-9. PubMed ID: 7690328
[TBL] [Abstract][Full Text] [Related]
2. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
Korthäuer U; Graf D; Mages HW; Brière F; Padayachee M; Malcolm S; Ugazio AG; Notarangelo LD; Levinsky RJ; Kroczek RA
Nature; 1993 Feb; 361(6412):539-41. PubMed ID: 7679206
[TBL] [Abstract][Full Text] [Related]
3. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM.
Saiki O; Tanaka T; Wada Y; Uda H; Inoue A; Katada Y; Izeki M; Iwata M; Nunoi H; Matsuda I
J Clin Invest; 1995 Feb; 95(2):510-4. PubMed ID: 7532185
[TBL] [Abstract][Full Text] [Related]
4. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome.
Agematsu K; Nagumo H; Shinozaki K; Hokibara S; Yasui K; Terada K; Kawamura N; Toba T; Nonoyama S; Ochs HD; Komiyama A
J Clin Invest; 1998 Aug; 102(4):853-60. PubMed ID: 9710455
[TBL] [Abstract][Full Text] [Related]
5. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression.
Durandy A; Hivroz C; Mazerolles F; Schiff C; Bernard F; Jouanguy E; Revy P; DiSanto JP; Gauchat JF; Bonnefoy JY; Casanova JL; Fischer A
J Immunol; 1997 Mar; 158(6):2576-84. PubMed ID: 9058789
[TBL] [Abstract][Full Text] [Related]
6. CD40 ligand and its role in X-linked hyper-IgM syndrome.
Callard RE; Armitage RJ; Fanslow WC; Spriggs MK
Immunol Today; 1993 Nov; 14(11):559-64. PubMed ID: 7506037
[TBL] [Abstract][Full Text] [Related]
7. CD40 ligand (CD40L) expression and B cell function in agammaglobulinemia with normal or elevated levels of IgM (HIM). Comparison of X-linked, autosomal recessive, and non-X-linked forms of the disease, and obligate carriers.
Callard RE; Smith SH; Herbert J; Morgan G; Padayachee M; Lederman S; Chess L; Kroczek RA; Fanslow WC; Armitage RJ
J Immunol; 1994 Oct; 153(7):3295-306. PubMed ID: 7916370
[TBL] [Abstract][Full Text] [Related]
8. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
[TBL] [Abstract][Full Text] [Related]
9. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction.
Klaus SJ; Pinchuk LM; Ochs HD; Law CL; Fanslow WC; Armitage RJ; Clark EA
J Immunol; 1994 Jun; 152(12):5643-52. PubMed ID: 7515910
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.
Gascan H; Gauchat JF; Aversa G; Van Vlasselaer P; de Vries JE
J Immunol; 1991 Jul; 147(1):8-13. PubMed ID: 1711085
[TBL] [Abstract][Full Text] [Related]
11. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
Conley ME; Larché M; Bonagura VR; Lawton AR; Buckley RH; Fu SM; Coustan-Smith E; Herrod HG; Campana D
J Clin Invest; 1994 Oct; 94(4):1404-9. PubMed ID: 7523449
[TBL] [Abstract][Full Text] [Related]
12. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines.
Armitage RJ; Macduff BM; Spriggs MK; Fanslow WC
J Immunol; 1993 May; 150(9):3671-80. PubMed ID: 8097223
[TBL] [Abstract][Full Text] [Related]
13. CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells.
Aversa G; Punnonen J; Carballido JM; Cocks BG; de Vries JE
Semin Immunol; 1994 Oct; 6(5):295-301. PubMed ID: 7532459
[TBL] [Abstract][Full Text] [Related]
14. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes.
Burdin N; Van Kooten C; Galibert L; Abrams JS; Wijdenes J; Banchereau J; Rousset F
J Immunol; 1995 Mar; 154(6):2533-44. PubMed ID: 7533177
[TBL] [Abstract][Full Text] [Related]
15. CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.
DiSanto JP; Bonnefoy JY; Gauchat JF; Fischer A; de Saint Basile G
Nature; 1993 Feb; 361(6412):541-3. PubMed ID: 8094231
[TBL] [Abstract][Full Text] [Related]
16. Localization of the genetic defect in X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1) to the CD40 ligand gene.
Fuleihan R; Ramesh N; Rosen FS; Geha RS
Trans Assoc Am Physicians; 1993; 106():91-5. PubMed ID: 7518624
[No Abstract] [Full Text] [Related]
17. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
[TBL] [Abstract][Full Text] [Related]
18. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns.
Durandy A; De Saint Basile G; Lisowska-Grospierre B; Gauchat JF; Forveille M; Kroczek RA; Bonnefoy JY; Fischer A
J Immunol; 1995 Feb; 154(4):1560-8. PubMed ID: 7530739
[TBL] [Abstract][Full Text] [Related]
19. The CD40 antigen and its ligand.
Banchereau J; Bazan F; Blanchard D; Brière F; Galizzi JP; van Kooten C; Liu YJ; Rousset F; Saeland S
Annu Rev Immunol; 1994; 12():881-922. PubMed ID: 7516669
[TBL] [Abstract][Full Text] [Related]
20. The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency.
Ochs HD; Hollenbaugh D; Aruffo A
Semin Immunol; 1994 Oct; 6(5):337-41. PubMed ID: 7532462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
